粘液性嚢胞腺腫の悪性化との鑑別に苦慮した膵未分化癌の1例

症例は70歳代の女性．7年前に膵尾部単純性嚢胞と診断され，経過観察中であった．4ヶ月持続する発熱と心窩部痛の精査を目的として入院した．入院時のCTでは多発肝腫瘍を認め，嚢胞内には結節病変を，嚢胞周囲には出血・感染を示唆する所見を認めた．以上より，嚢胞性病変が癌化して転移・浸潤をきたし，嚢胞周囲に膿瘍を形成したものと考えて対症的に治療したが，第15病日に死亡した．剖検所見から嚢胞の癌化は否定され，嚢胞に近接して発生した膵未分化癌と，肝転移，肺転移等の多臓器転移，腹膜播種と診断された

リュウキ ケイセイ オ テイ シタ ミブンカ ガタ イ ネンマク ナイ ガン ニ タイ シ ナイシキョウ チリョウ オ シコウ シタ 1 レイ

症例は67才男性.上部消化管内視鏡検査で胃前庭部前壁に0-I+IIc型隆起性病変を指摘され,生検結果は低分化型腺癌の診断であった.適応拡大病変と診断して内視鏡的胃粘膜下層剥離術(ESD)施行し適応拡大治癒切除であった.フォローの内視鏡で初回病変の近傍に0-I+IIc型の隆起を主体とした病変を認め,生検結果は印環細胞癌であり,再度ESDを施行した.初回病変のような,隆起を主体とした未分化型粘膜内癌の症例は稀である.二回目の病変の成因は,局所再発・腫瘍移植(implantation)・異時性癌のいずれか確定は困難であったが,貴重な症例と思われたので報告したA 67-year-old man was diagnosed with a small elevated undifferentiated gastric adenocarcinoma in situ and subsequently underwent endoscopic submucosal dissection (ESD). Curative resection was achieved. Fifteen months later, a new lesion was found near the ESD scar of the first lesion. This lesion was similarly elevated, and histopathological examination of the biopsy specimen revealed signet ring cell carcinoma. We performed ESD again for this lesion. Elevated early gastric cancer in which histological examination shows undifferentiated adenocarcinoma and depth M is very rare. We searched for elevated early undifferentiated gastric cancers in the PubMed and Ichushi databases and find only nine cases. The cause of the second lesion was suspected to be either local recurrence, or implantation or metachronous cancer, but it seemed to be very difficult to diagnose exactly. It should be careful observation, even if obtained curative resection of undifferentiated intramucosal gastric cancer by ESD

Safe Performance of Track Dilation and Bile Aspiration with ERCP Catheter in EUS-Guided Hepaticogastrostomy with Plastic Stents: A Retrospective Multicenter Study

Objectives: Endoscopic-ultrasound-guided hepaticogastrostomy (EUS-HGS) with plastic stent placement is associated with a high incidence of adverse events that may be reduced using an endoscopic retrograde cholangiopancreatography (ERCP) contrast catheter in the track dilation step. In this study, we evaluated the usefulness of track dilation and bile aspiration performed with an ERCP contrast catheter in EUS-HGS with plastic stent placement. Methods: In a multicenter setting, 22 EUS-HGS cases dilated with an ERCP contrast catheter were analyzed retrospectively and compared between a bile aspiration group and no bile aspiration group. Results: Overall, adverse events occurred in three (13.6%) cases of bile leakage, three (13.6%) cases of peritonitis, and one (4.5%) case of bleeding. Comparing patients with and without bile aspiration, 6 of the 11 patients (54.5%) with no bile aspiration had adverse events, whereas only 1 of the 11 patients (9.1%) who had bile aspiration, as much bile as possible, had an adverse event (bleeding). In univariate analysis, the only factor affecting the occurrence of adverse events was bile aspiration whenever possible (odds ratio, 12.0; 95%CI 1.12–128.84). Conclusions: In EUS-HGS with plastic stent placement, track dilation and bile aspiration with an ERCP contrast catheter may be useful in reducing adverse events